SciBase Holding AB (publ) (SCIB.ST)
SEK 0.37
(-6.03%)
SEK 0.37
(-6.03%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 23.24 Million SEK | 29.93% |
| 2022 | 17.89 Million SEK | 52.55% |
| 2021 | 11.72 Million SEK | 23.17% |
| 2020 | 9.52 Million SEK | 2.64% |
| 2019 | 9.27 Million SEK | 34.45% |
| 2018 | 6.89 Million SEK | 0.58% |
| 2017 | 6.85 Million SEK | 6.57% |
| 2016 | 6.43 Million SEK | 55.05% |
| 2015 | 4.15 Million SEK | 159.44% |
| 2014 | 1.6 Million SEK | 1549.48% |
| 2013 | 97 Thousand SEK | 0.0% |
| 2012 | - SEK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 6.64 Million SEK | 9.64% |
| 2024 Q1 | 6.05 Million SEK | 5.08% |
| 2023 Q2 | 5.08 Million SEK | -1.24% |
| 2023 FY | 23.24 Million SEK | 29.93% |
| 2023 Q4 | 5.76 Million SEK | -20.47% |
| 2023 Q3 | 7.24 Million SEK | 42.54% |
| 2023 Q1 | 5.14 Million SEK | 3.75% |
| 2022 Q1 | 4.26 Million SEK | 8.54% |
| 2022 Q4 | 4.96 Million SEK | 0.45% |
| 2022 FY | 17.89 Million SEK | 52.55% |
| 2022 Q2 | 3.72 Million SEK | -12.54% |
| 2022 Q3 | 4.94 Million SEK | 32.61% |
| 2021 Q1 | 2.56 Million SEK | -16.14% |
| 2021 FY | 11.72 Million SEK | 23.17% |
| 2021 Q4 | 3.92 Million SEK | 31.62% |
| 2021 Q3 | 2.98 Million SEK | 32.06% |
| 2021 Q2 | 2.25 Million SEK | -11.87% |
| 2020 Q1 | 2.49 Million SEK | -10.86% |
| 2020 FY | 9.52 Million SEK | 2.64% |
| 2020 Q4 | 3.05 Million SEK | 33.58% |
| 2020 Q3 | 2.28 Million SEK | 35.89% |
| 2020 Q2 | 1.68 Million SEK | -32.57% |
| 2019 FY | 9.27 Million SEK | 34.45% |
| 2019 Q4 | 2.8 Million SEK | 44.33% |
| 2019 Q3 | 1.94 Million SEK | -10.52% |
| 2019 Q2 | 2.16 Million SEK | -8.45% |
| 2019 Q1 | 2.36 Million SEK | 16.65% |
| 2018 Q2 | 1.57 Million SEK | -18.98% |
| 2018 Q4 | 2.03 Million SEK | 49.37% |
| 2018 Q1 | 1.93 Million SEK | 2.81% |
| 2018 FY | 6.89 Million SEK | 0.58% |
| 2018 Q3 | 1.35 Million SEK | -13.49% |
| 2017 FY | 6.85 Million SEK | 6.57% |
| 2017 Q2 | 2.04 Million SEK | 16.58% |
| 2017 Q4 | 1.88 Million SEK | 60.92% |
| 2017 Q1 | 1.75 Million SEK | -9.3% |
| 2017 Q3 | 1.17 Million SEK | -42.72% |
| 2016 Q1 | 1.06 Million SEK | -9.74% |
| 2016 Q3 | 1.58 Million SEK | -14.82% |
| 2016 Q2 | 1.85 Million SEK | 74.02% |
| 2016 Q4 | 1.93 Million SEK | 22.47% |
| 2016 FY | 6.43 Million SEK | 55.05% |
| 2015 Q3 | 995 Thousand SEK | 8.39% |
| 2015 Q2 | 918 Thousand SEK | -13.15% |
| 2015 Q1 | 1.05 Million SEK | 129.78% |
| 2015 FY | 4.15 Million SEK | 159.44% |
| 2015 Q4 | 1.18 Million SEK | 18.69% |
| 2014 Q3 | 818 Thousand SEK | 217.05% |
| 2014 Q4 | 460 Thousand SEK | -43.77% |
| 2014 Q2 | 258 Thousand SEK | 303.13% |
| 2014 Q1 | 64 Thousand SEK | 0.0% |
| 2014 FY | 1.6 Million SEK | 1549.48% |
| 2013 FY | 97 Thousand SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acarix AB (publ) | 6.24 Million SEK | -272.456% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 98.307% |
| ADDvise Group AB (publ) | 1.37 Billion SEK | 98.307% |
| Arcoma AB | 163.01 Million SEK | 85.741% |
| Bactiguard Holding AB (publ) | 203.99 Million SEK | 88.605% |
| BICO Group AB (publ) | 2.23 Billion SEK | 98.962% |
| Boule Diagnostics AB (publ) | 571.32 Million SEK | 95.931% |
| CellaVision AB (publ) | 677.29 Million SEK | 96.568% |
| Clinical Laserthermia Systems AB (publ) | 8.27 Million SEK | -180.974% |
| Chordate Medical Holding AB (publ) | 976.28 Thousand SEK | -2280.974% |
| C-Rad AB (publ) | 424.61 Million SEK | 94.526% |
| Duearity AB (publ) | 1.65 Million SEK | -1305.381% |
| Dignitana AB (publ) | 86.06 Million SEK | 72.991% |
| Episurf Medical AB (publ) | 10.3 Million SEK | -125.68% |
| Getinge AB (publ) | 31.82 Billion SEK | 99.927% |
| Scandinavian Real Heart AB (Publ) | - SEK | -Infinity% |
| Iconovo AB (publ) | 7.07 Million SEK | -228.399% |
| Integrum AB (publ) | 104.11 Million SEK | 77.675% |
| Luxbright AB (publ) | 854.69 Thousand SEK | -2619.671% |
| Mentice AB (publ) | 273.61 Million SEK | 91.504% |
| OssDsign AB (publ) | 112.15 Million SEK | 79.275% |
| Paxman AB (publ) | 210.11 Million SEK | 88.937% |
| Promimic AB (publ) | 37.07 Million SEK | 37.294% |
| Qlife Holding AB (publ) | 244 Thousand SEK | -9426.639% |
| ScandiDos AB (publ) | 60.42 Million SEK | 61.533% |
| Sectra AB (publ) | 2.96 Billion SEK | 99.216% |
| Sedana Medical AB (publ) | 153.86 Million SEK | 84.893% |
| Senzime AB (publ) | 35.75 Million SEK | 34.986% |
| SpectraCure AB (publ) | 318 Thousand SEK | -7209.748% |
| Stille AB | 294.89 Million SEK | 92.117% |
| Vitrolife AB (publ) | 3.51 Billion SEK | 99.338% |
| Xvivo Perfusion AB (publ) | 597.54 Million SEK | 96.11% |